I Was Right...But I Didn't Buy :-( Fri, Jun 29, 2018

VRTX $181.97 +1.47 (0.81%)

Vertex Pharmaceuticals Inc

Stock Charts Stock Price Earnings Industry Stocks Company Profile

Vertex Stock Charts

The 5 year and 1 year stock charts are below.

Vertex 5 year stock chart
Vertex 5 year stock chart

50 Day Moving Average

The 50 Day Moving Average is at $157.66 which is 15.42% below the stock price of $181.97.

200 Day Moving Average

The 200 Day Moving Average is at 156.30 which is 16.42% below the stock price of $181.97.

VRTX Stock Price

Below are a few key dates for the stock price.

Year To Date


The most recent stock price is $181.97.

The Year To Date (YTD) return is +19.00%.

52 Week Low

Jul 2017

The 52 Week Low stock price is $127.67 set on Tue, Jul 18, 2017 which is 363 days ago.

The current price per share is 42.53% above the 52 week low.

52 Week High


The 52 Week High stock price is $182.16 set on Mon, Jul 16, 2018 which is Today. View all of today's 52 week highs.

The current price per share is -0.10% below the 52 week high.

All Time High


The All Time High stock price is $182.16 set on Mon, Jul 16, 2018 which is Today.

The current price per share is -0.10% below the all time high.


Below is the EPS, P/E Ratio and Earnings Date.

The Earnings Per Share (EPS) is $0.88.

The Price To Earnings (P/E) Ratio is 204.19.

Earnings Dates

Stocks can make big percentage moves on the earnings announcement.

Companies announce earnings either before the market open or after the close.


The Earnings Release Date for Vertex Pharmaceuticals Inc was Wed, Jan 31, 2018.

Since this earnings release 166 days ago, the stock price is up by +9.27%.


The most recent Earnings Release Date was on Thu, Apr 26, 2018, which was 81 days ago.

Since this earnings date, the stock price is up by +17.29%.

Vertex Dividend

Below is important Dividend information.

VRTX currently does not pay a dividend.

You may like this list of best dividend stocks of 2018.

Biotech & Pharma Industry

Below are other stocks in the same industry as Vertex.

VRTX Company Profile

Learn more about Vertex.

Vertex Pharmaceuticals Inc LogoVertex Pharmaceuticals Inc is a Health Care stock that trades on the NASDAQ and has a market capitalization of $45.43 Billion.

http://www.vpharm.comVertex Pharmaceuticals Incorporated is engaged in discovering, developing, manufacturing and commercializing medicines for serious diseases. The Company is focused on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs in other indications. The Company's marketed medicines are ORKAMBI and KALYDECO. ORKAMBI (lumacaftor in combination with ivacaftor) is approved as a treatment for patients having two copies (homozygous) of the Delta-F508 (F508del) mutation in their cystic fibrosis transmembrane conductance regulator (CFTR) gene. KALYDECO (ivacaftor) is approved for the treatment of CF patients having the G551D mutation or other specified mutations in their CFTR gene. The Company's development programs in the field of CF include Tezacaftor (VX-661), VX-152, VX-440, VX-659, VX-445 and VX-371. VX-152, VX-440, VX-659 and VX-445 are CFTR corrector compounds.

Spend a few minutes browsing the Vertex Pharmaceuticals Inc, web site at http://www.vpharm.com.

For more information and analysis of VRTX, visit Bloomberg, Google Finance, Nasdaq, Yahoo Finance.